1-(3-Methyl-5-trifluoromethylpyridin-2-yl)piperazine → HCID 71251863, compound
Reaction equation
[O:1]=[S:2]1(=[O:20])[CH2:6][CH2:5][CH2:4][N:3]1[C:7]1[CH:15]=[CH:14][C:10]([C:11]([OH:13])=O)=[C:9]([S:16]([CH3:19])(=[O:18])=[O:17])[CH:8]=1.[CH3:21][C:22]1[C:23]([N:32]2[CH2:37][CH2:36][NH:35][CH2:34][CH2:33]2)=[N:24][CH:25]=[C:26]([C:28]([F:31])([F:30])[F:29])[CH:27]=1>>[O:20]=[S:2]1(=[O:1])[CH2:6][CH2:5][CH2:4][N:3]1[C:7]1[CH:15]=[CH:14][C:10]([C:11]([N:35]2[CH2:36][CH2:37][N:32]([C:23]3[C:22]([CH3:21])=[CH:27][C:26]([C:28]([F:31])([F:29])[F:30])=[CH:25][N:24]=3)[CH2:33][CH2:34]2)=[O:13])=[C:9]([S:16]([CH3:19])(=[O:18])=[O:17])[CH:8]=1Participants
3
Procedure
Using 4-(1,1-dioxo-1λ6-isothiazolidin-2-yl)-2-methanesulfonylbenzoic acid (319 mg) described in Preparation Example 22 and 1-(3-methyl-5-trifluoromethylpyridin-2-yl)piperazine (245 mg) described in Preparation Example 84 and by the reaction and treatment in the same manner as in Example 87, the title compound (449 mg) was obtained.
Workup
- customdescribed in Preparation Example 84 and by the reaction and treatment in the same manner as in Example 87
Sources & evidence
- ORD record
- ord-820947c999684dd1bf04cd1a51ed9f7c
- Source dataset
- uspto-grants-2014_08
- Patent number
- US08816079B2
Reaction notes
Loading…